South Korean wearable robotics startup Hurotics has secured 25 billion won (US$18.6 million) in Series A funding led by Atinum Investment. The round, announced on October 15, includes existing investors Stonebridge Ventures, Industrial Bank of Korea, AJU IB Investment, and Wonik Investment Partners, as well as new investor Mirae Asset Venture Investment. Strategic investors Daewoong, Naver, and Lotte also participated, bringing the company's cumulative funding to more than 33.5 billion won.
Series A funding and investor base
Atinum Investment led the Series A round, with follow-on investments from Stonebridge Ventures, Industrial Bank of Korea, AJU IB Investment, and Wonik Investment Partners. Daewoong, Naver, and Lotte joined as strategic investors from the healthcare, technology, and retail sectors, while Mirae Asset Venture Investment participated as a new financial investor. The round brings cumulative funding to more than 33.5 billion won, and Hurotics said it will work with these partners on hospital supply, distribution, international expansion, and software development.
H-Medi technology and certification
H-Medi is a medical gait rehabilitation robot worn like clothing and designed to analyze the wearer's gait in real time. Sensors supply the force needed to help patients walk while using their own muscles, and the system has received Class II combination medical device certification from South Korea's Ministry of Food and Drug Safety. The device uses a cable-and-tendon drive technology that mimics muscle contraction.
Clinical adoption and first US export
Since its commercial launch in September 2025, H-Medi has been adopted by Severance Hospital in Sinchon, Chung-Ang University Hospital, and Korea University Hospital. In June 2026, the company exported the device to the University of Illinois Chicago in the United States. The system is being used there for stroke rehabilitation research and physical therapist training, marking an early step in the company's overseas expansion.
International expansion and H-Care development
Hurotics will use the new funding to obtain overseas regulatory approvals for H-Medi and widen its distribution network. The company is also pursuing commercial opportunities in Japan and Southeast Asia while working with medical institutions to build evidence for its technology. In parallel, the startup will develop and mass-produce H-Care, a wearable robot designed to assist people with walking during everyday activities.
Physical AI data platform
Over the longer term, Hurotics aims to expand into a wearable physical artificial intelligence platform using gait data collected through its devices. Planned applications include personalized walking assistance and software that can help predict muscle loss and fall risks. The company expects its strategic investors to support hospital supply, distribution, international expansion, and software development.
Founding expertise in soft exosuits
Hurotics was founded in July 2022 by Giuk Lee, a professor in the Department of Mechanical Engineering at Chung-Ang University. Lee previously led research on clothing-based wearable robots at Harvard University's Wyss Institute and took part in the US Defense Advanced Research Projects Agency's Warrior Web project. His first-author study on wearable robots designed to assist walking and running was selected as a cover paper for the international journal Science in 2019.
Hurotics says the investment will accelerate the global rollout of H-Medi and the commercialization of H-Care. The company plans to combine its hardware with physical AI to deliver wearable robots that support health in daily life. Support from healthcare, technology, and retail investors reflects growing confidence in soft exosuit technology for rehabilitation and mobility.